In systemic autoimmune diseases, autoantibodies specific for α-enolase are detected more frequently in patients with active renal involvement. To analyze the properties of anti-α-enolase antibodies and the distribution of the enzyme in the cell, mouse monoclonal and polyclonal antibodies were obtained from mice immunized with a glutathione-S-transferase-α-enolase fusion protein. Anti-α-enolase antibodies were purified from patient sera on enolase from human kidney. Using these antibodies, the distribution of α-enolase in the cell was analyzed in subcellular fractions and in the cell membrane by flow cytometry and immunoprecipitation. Plasminogen binding was studied by an immunoenzymatic assay. We observed that α-enolase was present in the cytosol and membrane fractions obtained from kidney and U937 cells. By flow cytometry, mouse polyclonal anti-enolase antibodies, one monoclonal and 7/9 humananti-enolase antibodies bound the membrane of U937 cells. One monoclonal antibody and mouse polyclonal anti-enolase antibodies immunoprecipitated a 48-kDa molecule from surface-labeled U937 cells arid this molecule was recognized by rabbit anti-enolase antibodies. Both immunization-induced antibodies and 7/9 autoantibodies from patient sera inhibited the binding of plasminogen to α-enolase. The results show that α-enolase, an autoantigen in connective tissue diseases, is a cytoplasmic enzyme which is also expressed on the cell membrane, with which it is strongly associated. Anti-α-enolase autoantibodies isolated from patient sera recognize the membrane-associated form of the enzyme and/or interfere with its receptor function, thus inhibiting the binding of plasminogen. Autoantibodies specific for α-enolase could play a pathogenic role, either by a cytopathic effect or by interfering with membrane fibrinolytic activity.

Surface expression of a glycolytic enzyme, alpha-enolase, recognized by autoantibodies in connective tissue disorders

MOSCATO, STEFANIA;PRATESI, FEDERICO;SCAVUZZO, MARIA CONCETTA;MIGLIORINI, PAOLA
2000-01-01

Abstract

In systemic autoimmune diseases, autoantibodies specific for α-enolase are detected more frequently in patients with active renal involvement. To analyze the properties of anti-α-enolase antibodies and the distribution of the enzyme in the cell, mouse monoclonal and polyclonal antibodies were obtained from mice immunized with a glutathione-S-transferase-α-enolase fusion protein. Anti-α-enolase antibodies were purified from patient sera on enolase from human kidney. Using these antibodies, the distribution of α-enolase in the cell was analyzed in subcellular fractions and in the cell membrane by flow cytometry and immunoprecipitation. Plasminogen binding was studied by an immunoenzymatic assay. We observed that α-enolase was present in the cytosol and membrane fractions obtained from kidney and U937 cells. By flow cytometry, mouse polyclonal anti-enolase antibodies, one monoclonal and 7/9 humananti-enolase antibodies bound the membrane of U937 cells. One monoclonal antibody and mouse polyclonal anti-enolase antibodies immunoprecipitated a 48-kDa molecule from surface-labeled U937 cells arid this molecule was recognized by rabbit anti-enolase antibodies. Both immunization-induced antibodies and 7/9 autoantibodies from patient sera inhibited the binding of plasminogen to α-enolase. The results show that α-enolase, an autoantigen in connective tissue diseases, is a cytoplasmic enzyme which is also expressed on the cell membrane, with which it is strongly associated. Anti-α-enolase autoantibodies isolated from patient sera recognize the membrane-associated form of the enzyme and/or interfere with its receptor function, thus inhibiting the binding of plasminogen. Autoantibodies specific for α-enolase could play a pathogenic role, either by a cytopathic effect or by interfering with membrane fibrinolytic activity.
2000
Moscato, Stefania; Pratesi, Federico; Sabbatini, A; Chimenti, D; Scavuzzo, MARIA CONCETTA; Passatino, R; Bombardieri, S; Giallongo, A; Migliorini, Paola
File in questo prodotto:
File Dimensione Formato  
Moscato S Eur J Immunol 2000.pdf

solo utenti autorizzati

Tipologia: Versione finale editoriale
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 177.68 kB
Formato Adobe PDF
177.68 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11568/189431
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 61
  • ???jsp.display-item.citation.isi??? 57
social impact